Cargando…
Expression Profiling of Glioblastoma Cell Lines Reveals Novel Extracellular Matrix-Receptor Genes Correlated With the Responsiveness of Glioma Patients to Ionizing Radiation
Glioblastoma (GBM) is the most lethal and frequent type of brain tumor, leading patients to death in approximately 14 months after diagnosis. GBM treatment consists in surgical removal followed by radio and chemotherapy. However, tumors commonly relapse and the treatment promotes only a slight incre...
Autores principales: | Serafim, Rodolfo Bortolozo, da Silva, Patrick, Cardoso, Cibele, Di Cristofaro, Luis Fernando Macedo, Netto, Renato Petitto, de Almeida, Rodrigo, Navegante, Geovana, Storti, Camila Baldin, de Sousa, Juliana Ferreira, de Souza, Felipe Canto, Panepucci, Rodrigo, Moreira, Cristiano Gallina, Penna, Larissa Siqueira, Silva, Wilson Araujo, Valente, Valeria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240593/ https://www.ncbi.nlm.nih.gov/pubmed/34211843 http://dx.doi.org/10.3389/fonc.2021.668090 |
Ejemplares similares
-
RNA sequencing data of different grade astrocytoma cell lines
por: de Sousa, Juliana Ferreira, et al.
Publicado: (2020) -
DNA repair genes in astrocytoma tumorigenesis, progression and
therapy resistance
por: de Sousa, Juliana Ferreira, et al.
Publicado: (2019) -
Proto-Oncogenes and Cell Cycle Gene Expression in Normal and Neoplastic Oral Epithelial Cells Stimulated With Soluble Factors From Single and Dual Biofilms of Candida albicans and Staphylococcus aureus
por: Amaya Arbeláez, María Isabel, et al.
Publicado: (2021) -
Epigenetic therapy with inhibitors of histone methylation suppresses DNA damage signaling and increases glioma cell radiosensitivity
por: Gursoy-Yuzugullu, Ozge, et al.
Publicado: (2017) -
Macrophage Cell Membrane Coating on Piperine-Loaded MIL-100(Fe) Nanoparticles for Breast Cancer Treatment
por: Quijia, Christian Rafael, et al.
Publicado: (2023)